ADAG

Adagene (ADAG)

About Adagene (ADAG)

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Details

Daily high

$2.78

Daily low

$2.41

Price at open

$2.56

52 Week High

$3.19

52 Week Low

$1.30

Market cap

124.0M

Dividend yield

0.00%

Volume

294,603

Avg. volume

258,984

P/E ratio

-4.08

Adagene News